Progression of LIver Damage and Cardiometabolic Disorders in Non-alcoholic Fatty Liver dIsease: an Observational Cohort STUDY. The Plinio Study
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
Liver fibrosis is the most important prognostic factor in patients with non-alcoholic factor disease. Clinical and biological condition, as diabetes or mutation for PNPLA3, are well known factors associated with liver fibrosis onset and progression. However, little is known about biochemical factors predicting liver fibrosis evolution in large NAFLD populations.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:
• Patients aged 18 years old or more
• Patients with at least on of the following metabolic disorders
‣ Obesity
⁃ Diabetes
⁃ Arterial hypertension
⁃ Dyslipidemia
Locations
Other Locations
Italy
Day Service of Internal Medicine and Metabolic Disorders - Policlinico Umberto I - Sapienza University of Rome
RECRUITING
Rome
Contact Information
Primary
Francesco Baratta, MD, PI.
francesco.baratta@uniroma1.it
+390649972249
Backup
Daniele Pastori, MD, PI.
daniele.pastori@uniroma1.it
+390649972249
Time Frame
Start Date: 2011-11
Estimated Completion Date: 2036-12-31
Participants
Target number of participants: 2000
Related Therapeutic Areas
Sponsors
Leads: University of Roma La Sapienza